All News about Eli Lilly
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
Via Benzinga
Exposures
Product Safety
$1000 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today
September 24, 2024
Via Benzinga
Spotlight on Eli Lilly: Analyzing the Surge in Options Activity
September 23, 2024
Via Benzinga
In-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry
September 20, 2024
Via Benzinga
Looking Into Eli Lilly's Recent Short Interest
September 17, 2024
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
September 17, 2024
Via Benzinga
Investing in This Healthcare Stock Could Be Like Catching Nvidia at the Dawn of the AI Boom
September 22, 2024
Via The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
September 20, 2024
Via Benzinga
Topics
Fraud
Exposures
Legal
Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss
September 16, 2024
Via Benzinga
Exposures
Product Safety
3 Stocks to Buy and Hold Forever
September 14, 2024
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free